[go: up one dir, main page]

AR105316A1 - ANTIBODIES AGAINST THE TRANSFERRINE RECEIVER (ANTI-CD71), ANTI-CD71 ACTIVABLES ANTIBODIES AND THEIR METHODS OF USE - Google Patents

ANTIBODIES AGAINST THE TRANSFERRINE RECEIVER (ANTI-CD71), ANTI-CD71 ACTIVABLES ANTIBODIES AND THEIR METHODS OF USE

Info

Publication number
AR105316A1
AR105316A1 ARP160101268A ARP160101268A AR105316A1 AR 105316 A1 AR105316 A1 AR 105316A1 AR P160101268 A ARP160101268 A AR P160101268A AR P160101268 A ARP160101268 A AR P160101268A AR 105316 A1 AR105316 A1 AR 105316A1
Authority
AR
Argentina
Prior art keywords
antibodies
methods
activables
transferrine
receiver
Prior art date
Application number
ARP160101268A
Other languages
Spanish (es)
Inventor
Roland Desnoyers Luc
Yang Weaver Annie
Singh Shweta
Alexander Terrett Jonathan
Ann Tipton Kimberly
Gary Sagert Jason
Original Assignee
Cytomx Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytomx Therapeutics Inc filed Critical Cytomx Therapeutics Inc
Publication of AR105316A1 publication Critical patent/AR105316A1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente se refiere en general a anticuerpos que unen CD71, anticuerpos activables que se unen específicamente con CD71 y métodos de preparación y uso de estos anticuerpos anti-CD71 y anticuerpos activables anti-CD71 en una variedad de indicaciones terapéuticas, diagnósticas y preventivas.This refers in general to antibodies that bind CD71, activatable antibodies that specifically bind with CD71 and methods of preparing and using these anti-CD71 antibodies and activatable anti-CD71 antibodies in a variety of therapeutic, diagnostic and preventive indications.

ARP160101268A 2015-05-04 2016-05-04 ANTIBODIES AGAINST THE TRANSFERRINE RECEIVER (ANTI-CD71), ANTI-CD71 ACTIVABLES ANTIBODIES AND THEIR METHODS OF USE AR105316A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562156838P 2015-05-04 2015-05-04

Publications (1)

Publication Number Publication Date
AR105316A1 true AR105316A1 (en) 2017-09-27

Family

ID=59981605

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP160101268A AR105316A1 (en) 2015-05-04 2016-05-04 ANTIBODIES AGAINST THE TRANSFERRINE RECEIVER (ANTI-CD71), ANTI-CD71 ACTIVABLES ANTIBODIES AND THEIR METHODS OF USE

Country Status (1)

Country Link
AR (1) AR105316A1 (en)

Similar Documents

Publication Publication Date Title
ECSP18007905A (en) MONOCLONAL ANTIBODIES AGAINST BCMA
MX2016016771A (en) MONOCLONAL ANTIBODIES AGAINST THE HER2 EPITHOPE AND ITS METHODS OF USE.
SV2018005684A (en) ANTIBODIES THAT SPECIFICALLY JOIN PD-1 AND ITS USES
MX388350B (en) ANTI-CD166 ANTIBODIES, ACTIVATABLE ANTI-CD166 ANTIBODIES, AND METHODS OF USING THE SAME.
MX2017014139A (en) ANTI-CD71 ANTIBODIES, ACTIVABLE ANTI-CD71 ANTIBODIES, AND METHODS OF USE OF THE SAME.
MX2023005879A (en) BISPECIFIC ANTIBODIES AGAINST HUMAN CD20 AND THE HUMAN TRANSFERRIN RECEPTOR AND METHODS OF USE.
CL2018000729A1 (en) Bispecific antibodies against human a-beta and the human transferrin receptor and methods of use.
MX2017007585A (en) Anti-c10orf54 antibodies and uses thereof.
CL2017001361A1 (en) Heterodimeric antibodies that bind to cd3 and cd38
CL2017000711A1 (en) Bispecific monovalent diabodies that are able to bind cd19 and cd3, and uses thereof.
PH12016501894B1 (en) Anti-ox40 antibodies and methods of use
MX374788B (en) ANTI-TIM3 ANTIBODIES AND METHODS OF USE.
MX386587B (en) ANTI-CD79b ANTIBODIES AND METHODS OF USE.
CL2016002455A1 (en) Multispecific antibodies.
CR20150618A (en) ANTITRANSPHERINE RECEIVING ANTIBODIES AND METHODS OF USE
MX388018B (en) ANTI-PD1 ANTIBODIES AND METHODS OF USE.
MX2015017487A (en) HUMANIZED OR CHEMICAL CD3 ANTIBODIES.
PH12015501954A1 (en) Anti-b7-h4 antibodies and immunoconjugates
BR112017011932A2 (en) G protein coupled receptor-directed antibodies and methods of use
MX2017003022A (en) Anti-cll-1 antibodies and immunoconjugates.
AR115052A1 (en) MULTI-SPECIFIC ANTIBODIES AND THE USE OF THEM
MX372675B (en) ANTI-JAGGED1 ANTIBODIES AND METHODS OF USE.
CL2018000298A1 (en) Anti-cd154 antibodies and methods of use of these.
CL2017003295A1 (en) Antibodies against human csf-1r for use in the induction of lymphocytosis in lymphomas or leukemias
CL2016002892A1 (en) Ang2 antibodies

Legal Events

Date Code Title Description
FA Abandonment or withdrawal